NEW YORK (GenomeWeb News) — Accelrys will shut down its R&D shop in Bangalore, India, as it nears the end of a restructuring plan and efforts to “modernize its legacy products,” the company said today in a Securities and Exchange Commission filing.
The company also said it will lay-off 60 employees who work at the facility and will pay out around $700 thousand to $900 thousand in mostly cash in severance and costs associated with the closure.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.